Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

Repligen enters into development agreement for uridine for bipolar disorder

March 18, 2005

Phase I study of Acrux transdermal spray to prevent nausea in cancer patients

March 18, 2005

CGRP receptor antagonists reported by Merck

March 17, 2005

Ionix Pharmaceuticals described sodium channel blockers

March 17, 2005

European approval for Zonegran

March 17, 2005

Preclinical neuroprotective and cognitive-enhancing effects of EHT-0202

March 17, 2005

CEP-1347 inhibits the c-Jun N-terminal kinase cascade to evoke apoptosis

March 17, 2005

Clarithromycin reported to increase the antiparkinsonian effects of cabergoline

March 17, 2005

Viprinex set for phase III in the summer

March 17, 2005

Savient terminating phase II Prosaptide study

March 17, 2005

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...